Mindbio Therapeutics Corp. (TSE:MBIO) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
MindBio Therapeutics Corp. has successfully completed a private placement, raising $200,390 from five investors and issuing 6,909,986 shares. Additionally, Riverfort Global Opportunities converted CAD$50,000 of its loan into 1,000,000 shares, supporting MindBio’s ongoing Phase 2B trials expected to finish in 2025.
For further insights into TSE:MBIO stock, check out TipRanks’ Stock Analysis page.
